ArticleThe patient2022

The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer.

Andrea Bever et al.PubMed ↗Publisher ↗

No numbers read from the abstract.